Skip to content
CompanySight
Company No. 09904280 · Incorporated 7 Dec 2015

Medsolutions (Europe) Limited

Registered name: MEDSOLUTIONS (EUROPE) LIMITED

Part of Zydus Pharmaceuticals UK Ltd group

Medsolutions (Europe) Limited does not publish its revenue or profit. Its accounts to 31 Mar 2024 show net assets of £99k.

Medsolutions (Europe) Limited did not publish its revenue or profit — small companies aren’t required to file a profit & loss account. Its accounts for the year to 31 Mar 2024 showed net assets of £99k and 0 employees. The company is classified under “manufacture of other chemical products” and is based in Northampton; we hold 4 years of its filed accounts.

Status
Active
Location
Northampton, East Midlands
Age
10 yrs · since 2015
Type
Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently. From the filing: “Zydus Pharmaceuticals UK Limited is the controlling party.”

Latest accounts · year to 31 Mar 2024

Key figures

Small team

Revenue not disclosed

Medsolutions (Europe) Limited’s accounts for the year to 31 Mar 2024 contain a balance sheet but no profit & loss account, so its revenue and profit are not public. UK small and micro-entity companies are not required to publish a P&L — this is normal and says nothing about how the business is performing.

We never estimate revenue. Below you’ll find the balance-sheet figures that were filed — useful as indirect signals of momentum, but they are not revenue or profit.

Employees
0
Net assets
£99k

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

4 filed years

Financial history

Multi-year financials, oldest to newest
Year to30 Jun 202231 Dec 20226 Nov 202331 Mar 2024
DisclosureNo P&LNo P&LNo P&LNo P&L
Profit & loss
Revenue (turnover)————
Profit (best available)————
Employees (average)4400
Ratios
Profit margin————
Balance sheet — indirect signals, not revenue
Cash at bank£29£104k£440£8.4k
Net assets£47.1k£46.3k−£137k£99k
Current assets£62.3k£320k£16.4k£255k
Debtors£0£216k£16k£213k
SourceFullAccounts · bulk data Oct 2023FullAccounts · bulk data Oct 2023FilletedAccounts · bulk data Nov 2024FilletedAccounts · bulk data Feb 2025
Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets
—
Now £99k
Cash at bank
—
Now £8.4k
Headcount
—
Now 0
Deferred income
—
Now —
Fixed assets
—
Now —
Corporate ownership

Group structure

Ownership chain

  1. Zydus Pharmaceuticals UK Ltdultimate parent75–100%
  2. Medsolutions (Europe) Limitedthis company

Bands show the share of ownership each company holds in the one below it.

Sister companies (4)

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Latest figures from FilletedAccounts for the year to 31 Mar 2024, from the Companies House accounts bulk data published Feb 2025. Spotted an error? Request a correction.

Updated from Companies House on 15 Oct 2026

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.